All In Biotech

Free tool

FAERS Monitor: Topotecan Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 200582 or its brand name (Topotecan Hydrochloride, Topotecan Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,353

Serious

5,108

95% of reports

Hospitalization

2,147

Death reported

1,065

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use551
  • febrile neutropenia530
  • neutropenia472
  • anaemia415
  • disease progression382
  • pyrexia370
  • vomiting361
  • product use in unapproved indication360
  • thrombocytopenia359
  • nausea318
  • malignant neoplasm progression296
  • drug ineffective267
  • pancytopenia250
  • diarrhoea248
  • fatigue241

Reports by year received

View as table
YearReports
200481
2005135
200688
2007121
2008107
2009137
2010162
2011189
2012184
2013129
2014185
2015281
2016302
2017281
2018323
2019256
2020388
2021425
2022368
2023312
2024323
2025383
2026193

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,806 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal53031.629.215,618
pancytopeniaSignal25017.715.63,903
neutropeniaSignal47213.712.65,553
disease progressionSignal38212.711.54,124
thrombocytopeniaSignal35912.711.43,849
malignant neoplasm progressionSignal29611.410.22,800
anaemiaSignal4158.67.82,785
product use in unapproved indicationSignal3605.75.21,410
pyrexiaSignal3704.23.8915
vomitingSignal3613.02.7496
off label useSignal5512.52.3503
nausea3181.61.470
diarrhoea2481.51.343
fatigue2411.21.19
drug ineffective2670.80.715

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.